Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 14, 2024

Quadram and SKAN partner for microbial therapies development

Quadram Institute Bioscience and SKAN Research Trust have embarked on a collaborative project to develop new microbial therapies using advanced genetic sequencing platform.

The alliance between Quadram and SKAN will harness the potential of traditional medical compounds in the fight against bacterial infections. Credit: COPYRIGHT © 2023 SKAN RESEARCH TRUST - ALL RIGHTS RESERVED.